AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results

AngioDynamics (NASDAQ:ANGO) issued its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.03, MarketWatch Earnings reports. AngioDynamics had a negative net margin of 62.90% and a positive return on equity of 0.18%. The business had revenue of $72.80 million for the quarter, compared to the consensus estimate of $67.33 million. During the same quarter in the previous year, the firm earned $0.06 earnings per share. The company’s revenue for the quarter was up 4.0% on a year-over-year basis.

ANGO traded up $0.23 during trading hours on Friday, hitting $18.80. The company’s stock had a trading volume of 8,777 shares, compared to its average volume of 240,508. The business’s 50-day moving average price is $14.29 and its 200-day moving average price is $11.16. AngioDynamics has a 12 month low of $7.48 and a 12 month high of $19.52. The stock has a market cap of $713.46 million, a price-to-earnings ratio of -4.18 and a beta of 0.89. The company has a current ratio of 3.57, a quick ratio of 2.25 and a debt-to-equity ratio of 0.09.

Several equities analysts have recently commented on the stock. Raymond James boosted their target price on shares of AngioDynamics from $18.00 to $24.00 and gave the stock a “strong-buy” rating in a report on Friday. Zacks Investment Research downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating and set a $15.00 target price on the stock. in a report on Tuesday, December 1st. BidaskClub raised shares of AngioDynamics from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Canaccord Genuity boosted their target price on shares of AngioDynamics from $14.00 to $18.00 and gave the stock a “hold” rating in a report on Friday. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $19.00.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

Recommended Story: Growth Stocks

Earnings History for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.